14/03/2025
BIOS and OncoInv have partnered to make multi-cancer early detection more accessible in Pakistan. OncoSeek® is an advanced, patient-friendly solution that detects nine types of cancer using a simple blood test.
With over 185,000 new cancer cases reported annually in Pakistan—many diagnosed at advanced stages—early detection is more critical than ever. BIOS has collaborated with OncoInv to introduce OncoSeek, a groundbreaking Multi-Cancer Early Detection (MCED) test. This non-invasive, highly accurate blood-based screening detects nine high-mortality cancers, including Breast, Colorectal, Liver, Lung, Lymphoma, Esophagus, O***y, Pancreas, and Stomach, while also identifying the Tissue of Origin (ToO) to support targeted diagnostic follow-ups.
By bringing OncoSeek to Pakistan, BIOS is committed to making early cancer detection more accessible, affordable, and effective. With a nationwide presence—including offices in Karachi, Islamabad, Lahore, and Peshawar, along with regional teams across the country—BIOS is dedicated to ensuring this transformative technology reaches those who need it most. Through this collaboration with OncoInv, BIOS aims to drive a shift from late-stage diagnoses to early detection, improving survival outcomes—because every life matters.
Read more about OncoSeek® at https://rb.gy/e9xwhw
